Price data is not available
Tema Oncology ETF (CANC) Stock Price, Quote, News & History
CANCNASDAQ
AI and genomics could fuel a biotech ETF re-rating as health care trades at a discount, says Dr. David Song, MD, PhD.
You can purchase shares of Tema Oncology ETF (NASDAQ:CANC) through any online brokerage.
There are no as such competitors for Tema Oncology ETF.
There is no analysis for Tema Oncology ETF to provide a consensus price target.
The stock price for Tema Oncology ETF (NASDAQ: CANC) is $42.47 last updated October 20, 2026 at 6:22 PM EDT.
There are no upcoming dividends for Tema Oncology ETF.
Tema Oncology ETF does not have any upcoming earnings scheduled.
There is no upcoming split for Tema Oncology ETF.
The Tema Oncology ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The...
